Immuron

Analyst Reports

Corporate Governance

Corporate Directory

Corporate

Capital Structure & Register

Annual Reports

Investor Presentations

NASDAQ

Investors

Company Media

Announcements

The Digest

Why Immuron?

Home

Plus Jakarta Sans

Click here to read full article

Travelan®, Immuron’s over-the-counter oral immunotherapy, leverages hyperimmune bovine colostrum to deliver targeted polyclonal antibodies in the gut that bind and neutralise enteric pathogens like ETEC and their toxins—preventing traveler’s diarrhoea without promoting antibiotic resistance. Manufactured using colostrum from New Zealand dairy herds immunised under strict animal welfare protocols via Immuron’s partner Synlait, the product has gained traction among consumers seeking antimicrobial alternatives, with demand increasing alongside travel resurgence.

The West Australian: Beating bacteria just got boosted